TNM staging system Antibody Drug Conjugate (ADCs) Clinical stage Grade 3, 4, or 5 Carcinoma Tumor Refractory Surgical margin Chemotherapy Partial Remission Minimal residual disease (MRD) Tyrosine kinase inhibitors (TKIs) Checkpoint inhibitor Sarcoma Neoadjuvant treatment Definitive treatment Adjuvant treatment Adenocarcinoma Pathological stage Complementary therapy CTACAE Complete remission Cellular therapy Active surveillance Recurrence Maintenance chemotherapy Maintenance chemotherapy performance status Monoclonal antibody Relapse ECOG performance status Cure Palliation leukemia TNM staging system Antibody Drug Conjugate (ADCs) Clinical stage Grade 3, 4, or 5 Carcinoma Tumor Refractory Surgical margin Chemotherapy Partial Remission Minimal residual disease (MRD) Tyrosine kinase inhibitors (TKIs) Checkpoint inhibitor Sarcoma Neoadjuvant treatment Definitive treatment Adjuvant treatment Adenocarcinoma Pathological stage Complementary therapy CTACAE Complete remission Cellular therapy Active surveillance Recurrence Maintenance chemotherapy Maintenance chemotherapy performance status Monoclonal antibody Relapse ECOG performance status Cure Palliation leukemia
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
TNM staging system
Antibody Drug Conjugate (ADCs)
Clinical stage
Grade 3, 4, or 5
Carcinoma
Tumor
Refractory
Surgical margin
Chemotherapy
Partial Remission
Minimal residual disease (MRD)
Tyrosine kinase inhibitors (TKIs)
Checkpoint inhibitor
Sarcoma
Neoadjuvant treatment
Definitive treatment
Adjuvant treatment
Adenocarcinoma
Pathological stage
Complementary therapy
CTACAE
Complete remission
Cellular therapy
Active surveillance
Recurrence
Maintenance chemotherapy
Maintenance chemotherapy
performance status
Monoclonal antibody
Relapse
ECOG performance status
Cure
Palliation
leukemia